Insmed
INSM
129 hedge funds and large institutions have $2.37B invested in Insmed in 2017 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 56 increasing their positions, 46 reducing their positions, and 36 closing their positions.
22% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 46
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
18% more call options, than puts
Call options by funds: $7.19M | Put options by funds: $6.09M
3.03% more ownership
Funds ownership: 96.08% → 99.11% (+3%)
3% more capital invested
Capital invested by funds: $2.3B → $2.37B (+$65.5M)
12% less funds holding
Funds holding: 146 → 129 (-17)
44% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 36
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$59.2M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$48.4M |
| 3 |
State Street
Boston,
Massachusetts
|
+$33.6M |
| 4 |
BlackRock
New York
|
+$24.2M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$21.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$47M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$23.8M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$22.6M |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$12.7M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$12M |
INSM Hedge Fund Activity: Q4 2017 in Review
129 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q4 2017, worth a combined $2.37B — up 2.8% from $2.3B a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of INSM and 20 opened new positions — a net loss of 16 holders — while 46 trimmed existing stakes and 56 added.
The largest buyer was Janus Henderson Group, adding an estimated $59.2M. The largest seller was Jennison Associates, exiting entirely with an estimated $47M sold.
- 129 institutional investors held Insmed (INSM) as of Q4 2017, down from 146 in Q3 2017.
- Funds reported $2.37B of Insmed stock for Q4 2017, up 2.8% quarter-over-quarter.
- 20 funds opened new Insmed positions in Q4 2017 and 36 closed out, a net change of -16 holders.
- The largest Insmed buyer in Q4 2017 was Janus Henderson Group, an estimated $59.2M added.
- The largest Insmed seller in Q4 2017 was Jennison Associates, an estimated $47M sold.
Based on aggregated 13F filings for Q4 2017.